Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging

Circulation

Volumn 109, Issue 23, 2004, Pages 2890-2896

  Sirol, Marc ^a   Itskovich, Vitalii V ^a   Mani, Venkatesh ^d   Aguinaldo, Juan Gilberto S ^a   Fallon, John T ^a   Misselwitz, Bernd ^b   Weinmann, Hanns Joachim ^b   Fuster, Valentin ^a   Toussaint, Jean François ^c   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BAYER PHARMA AG   (Germany)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Box 1030 ^*

Author keywords

Atherosclerosis; Contrast media; Magnetic resonance imaging; Plaque

Indexed keywords

FLUORINE DERIVATIVE; GADOFLUORINE; LIPID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SCREENING; EARLY DIAGNOSIS; FEMALE; IMAGE ENHANCEMENT; INJECTION; INTERMETHOD COMPARISON; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

ANIMALS; AORTA, ABDOMINAL; AORTIC DISEASES; ARTERIOSCLEROSIS; BALLOON DILATATION; CONTRAST MEDIA; DIET, ATHEROGENIC; FIBROSIS; LIPIDS; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; RABBITS;

EID: 2942670674     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000129310.17277.E7     Document Type: Article

References (34)

1. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet. 1999;353(suppl 2):SII5-SII9.
2. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316: 1371-1375.
3. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
4. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506-510.
5. Yuan C, Mitsumori LM, Beach KW, et al. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;221:285-299.
6. Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368-1373.
7. Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging. 2002;15:62-67.
8. Wasserman BA, Smith WI, Trout HH III, et al. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology. 2002;223: 566-573.
9. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851-856.
10. Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453-2458.
11. Barkhausen J, Ebert W, Heyer C, et al. Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging. Circulation. 2003;108:605-609.
12. Helft G, Worthley SG, Fuster V, et al, Atherosclerotic aortic component quantification by noninvasive magnetic resonance: an in vivo study in rabbits. J Am Coll Cardiol. 2001;37:1149-1154.
13. Worthley SG, Helft G, Fuster V, et al. Serial In vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation. 2000; 101:586-589.
14. Misselwitz B, Platzek J, Raduchel B, et al. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography. Magma. 1999;8:190-195.
15. Staatz G, Nolte-Ernsting CCA, Adam GB, et al. Interstitial T1-weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs. Radiology. 2001;220:129-134.
16. Misselwitz B, Platzek J, Weinmann HJ. Early intravenous MR lymphography with gadofluorine M in rabbits. Radiology. In press.
17. Edelman R, Wallner B, Singer A, et al. Segmented turboFLASH: method for breath-hold MR imaging of the liver with flexible contrast. Radiology. 1990;177:515-521.
18. Pell GS, Lewis DP, Branch CA. Pulsed arterial spin labeling using turboFLASH with suppression of intravascular signal. Magn Reson Med. 2003;49:341-350.
19. Fayad ZA, Fallon JT, Shinnar M, et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998;98:1541-1547.
20. Garvey W. Modified elastic tissue-Masson trichrome stain. Stain Technol. 1984;59:213-216.
21. Mitchinson MJ. Insoluble lipids in human atherosclerotic plaques. Atherosclerosis. 1982;45:11-15.
22. Shimada M, Yoshikawa K, Suganuma T, et al. Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine-pentaacetic acid. J Comput Assist Tomogr. 2003;27:641-646.
23. Colangelo S, Langille BL, Steiner G, et al. Alterations in endothelial F-actin microfilaments in rabbit aorta in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1998;18:52-56.
24. Purushothaman K-R, Fuster V, O'Connor WN, et al. Neovascularization is the most powerful independent predictor for progression to disruption in high-risk atherosclerotic plaques. J Am Coll Cardiol. 2003; 41(suppl 2):352-353.
25. Merbach AA, Toth E. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Chichester, UK: John Wiley & Sons; 2001.
26. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/ dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR. 1984;16:167-172.
27. Niendorf HP, Alhassan A, Balzer T, et al. Safety and Risk of Gadolinium-DTPA: Extended Clinical Experience After More Than 20 Million Applications. 3rd rev ed. Berlin, Germany: Blackwell Wissenschafts-Verlag GmbH; 1996.
28. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation. 2003;107: 2068-2071.
29. Henkelman RM, Neil JJ, Xiang QS. A quantitative interpretation of IVIM measurements of vascular perfusion in the rat brain. Magn Reson Med. 1994;32:464-469.
30. Jara H, Yu BC, Caruthers SD, et al. Voxel sensitivity function description of flow-induced signal loss in MR imaging: implications for black-blood MR angiography with turbo spin-echo sequences. Magn Reson Med. 1999;41:575-590.
31. Toussaint JF, Southern JF, Fuster V, et al. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1533-1542.
32. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-938.
33. Zhang S, Cai J, Luo Y, et al. Measurement of carotid wall volume and maximum area with contrast-enhanced 3D MR imaging: initial observations. Radiology. 2003;228:200-205.
34. Fayad ZA, Fuster V, Nikolaou K, et al. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002; 106:2026-2034.